Details for 2022165237

Up to date per 23.05.2026

Actions

Title / Product Name

PRC2-INHIBITOREN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2022165237

EP Publication Number

4043466

E-Number

1715406

Language

PCT Number

Publication Date

17.08.2022 A

21.08.2024 B1

Registration Date

21.08.2024

AT Publication Date

15.09.2024

Application Date

29.01.2019

Registration Number

Priorities

31.01.2018

201862624176 P

17.05.2018

201862672701 P

19.10.2018

201862747736 P

IPC

C07D 487/04 20060101AFI20220707BHEP

Maximum Duration of Protection

29.01.2039

Owner

Mirati Therapeutics, Inc.Route 206 and Province Line Road Princeton, New Jersey 08543US

Representative

No representatives present

Inventor

MARX, Matthew, Arnold San Diego 92127US

LEE, Matthew, Randolph Del Mar 92014US

BOBINSKI, Thomas, P. San Diego 92122-4647US

BURNS, Aaron, Craig San Diego 92128US

ARORA, Nidhi San Diego 92130US

CHRISTENSEN, James, Gail San Diego 92130US

KETCHAM, John. Michael San Diego 92111US

Information about Fees